69 related articles for article (PubMed ID: 16290264)
21. GABA(B) receptor activation inhibits dopamine D1 receptor-mediated facilitation of [(3)H]GABA release in substantia nigra pars reticulata.
Nava-Asbell C; Paz-Bermudez F; Erlij D; Aceves J; Florán B
Neuropharmacology; 2007 Oct; 53(5):631-7. PubMed ID: 17868750
[TBL] [Abstract][Full Text] [Related]
22. Involvement of mitochondrial alteration and reactive oxygen species generation in Taiwan cobra cardiotoxin-induced apoptotic death of human neuroblastoma SK-N-SH cells.
Chen KC; Lin SR; Chang LS
Toxicon; 2008 Aug; 52(2):361-8. PubMed ID: 18619991
[TBL] [Abstract][Full Text] [Related]
23. Enhanced dopamine D2 receptor function in hypothalamus and corpus striatum: their role in liver, plasma and in vitro hepatocyte ALDH regulation in ethanol treated rats.
Akash KG; Anju TR; Peeyush KT; Paulose CS
J Biomed Sci; 2008 Sep; 15(5):623-31. PubMed ID: 18536982
[TBL] [Abstract][Full Text] [Related]
24. Hippocampal modulation of locomotor activity induced by focal activation of postsynaptic dopamine receptors in the core of the nucleus accumbens.
Rouillon C; Abraini JH; David HN
Hippocampus; 2007; 17(11):1028-36. PubMed ID: 17604350
[TBL] [Abstract][Full Text] [Related]
25. Identification and characterization of functional D1 dopamine receptors in a human neuroblastoma cell line.
Sidhu A; Fishman PH
Biochem Biophys Res Commun; 1990 Jan; 166(2):574-9. PubMed ID: 2154212
[TBL] [Abstract][Full Text] [Related]
26. Where do you think you are going? The NMDA-D1 receptor trap.
Cepeda C; Levine MS
Sci STKE; 2006 May; 2006(333):pe20. PubMed ID: 16670371
[TBL] [Abstract][Full Text] [Related]
27. In vitro characterization of SLV308 (7-[4-methyl-1-piperazinyl]-2(3H)-benzoxazolone, monohydrochloride): a novel partial dopamine D2 and D3 receptor agonist and serotonin 5-HT1A receptor agonist.
Glennon JC; Van Scharrenburg G; Ronken E; Hesselink MB; Reinders JH; Van Der Neut M; Long SK; Feenstra RW; McCreary AC
Synapse; 2006 Dec; 60(8):599-608. PubMed ID: 17001660
[TBL] [Abstract][Full Text] [Related]
28. Differential electrophysiological properties of dopamine D1 and D2 receptor-containing striatal medium-sized spiny neurons.
Cepeda C; André VM; Yamazaki I; Wu N; Kleiman-Weiner M; Levine MS
Eur J Neurosci; 2008 Feb; 27(3):671-82. PubMed ID: 18279319
[TBL] [Abstract][Full Text] [Related]
29. Dopamine profoundly suppresses excitatory transmission in neonatal rat hippocampus via phosphatidylinositol-linked D1-like receptor.
Noriyama Y; Ogawa Y; Yoshino H; Yamashita M; Kishimoto T
Neuroscience; 2006; 138(2):475-85. PubMed ID: 16406680
[TBL] [Abstract][Full Text] [Related]
30. Differential effects of impaired mitochondrial energy production on the function of mu and delta opioid receptors in neuronal SK-N-SH cells.
Raut A; Iglewski M; Ratka A
Neurosci Lett; 2006 Aug; 404(1-2):242-6. PubMed ID: 16808998
[TBL] [Abstract][Full Text] [Related]
31. Altered D(1) dopamine receptor trafficking in parkinsonian and dyskinetic non-human primates.
Guigoni C; Doudnikoff E; Li Q; Bloch B; Bezard E
Neurobiol Dis; 2007 May; 26(2):452-63. PubMed ID: 17350277
[TBL] [Abstract][Full Text] [Related]
32. S33138 [N-[4-[2-[(3aS,9bR)-8-cyano-1,3a,4,9b-tetrahydro[1]-benzopyrano[3,4-c]pyrrol-2(3H)-yl)-ethyl]phenylacetamide], a preferential dopamine D3 versus D2 receptor antagonist and potential antipsychotic agent. II. A neurochemical, electrophysiological and behavioral characterization in vivo.
Millan MJ; Svenningsson P; Ashby CR; Hill M; Egeland M; Dekeyne A; Brocco M; Di Cara B; Lejeune F; Thomasson N; Munoz C; Mocaër E; Crossman A; Cistarelli L; Girardon S; Iob L; Veiga S; Gobert A
J Pharmacol Exp Ther; 2008 Feb; 324(2):600-11. PubMed ID: 18024787
[TBL] [Abstract][Full Text] [Related]
33. Cooperative activation of D1-like and D2-like dopamine receptors in the nucleus accumbens shell is required for the reinstatement of cocaine-seeking behavior in the rat.
Schmidt HD; Pierce RC
Neuroscience; 2006 Oct; 142(2):451-61. PubMed ID: 16844308
[TBL] [Abstract][Full Text] [Related]
34. Induction of dopamine biosynthesis by l-DOPA in PC12 cells: implications of L-DOPA influx and cyclic AMP.
Jin CM; Yang YJ; Huang HS; Lim SC; Kai M; Lee MK
Eur J Pharmacol; 2008 Sep; 591(1-3):88-95. PubMed ID: 18602388
[TBL] [Abstract][Full Text] [Related]
35. Extracellular cAMP inhibits D1 dopamine receptor expression in CAD catecholaminergic cells via A2a adenosine receptors.
Do T; Sun Q; Beuve A; Kuzhikandathil EV
J Neurochem; 2007 May; 101(3):619-31. PubMed ID: 17254022
[TBL] [Abstract][Full Text] [Related]
36. D2-like but not D1-like dopamine receptors are involved in the ventrolateral orbital cortex-induced antinociception: a GABAergic modulation mechanism.
Sheng HY; Qu CL; Huo FQ; Du JQ; Tang JS
Exp Neurol; 2009 Jan; 215(1):128-34. PubMed ID: 18952080
[TBL] [Abstract][Full Text] [Related]
37. Interaction of caveolin-1, nitric oxide, and nitric oxide synthases in hypoxic human SK-N-MC neuroblastoma cells.
Shen J; Lee W; Li Y; Lau CF; Ng KM; Fung ML; Liu KJ
J Neurochem; 2008 Oct; 107(2):478-87. PubMed ID: 18717816
[TBL] [Abstract][Full Text] [Related]
38. Cys2,7EtalphaCGRP is a potent agonist for CGRP1 receptors in SK-N-MC cells.
Nodin C; Vauquelin G; von Mentzer B
Biochem Pharmacol; 2005 Apr; 69(8):1235-40. PubMed ID: 15794944
[TBL] [Abstract][Full Text] [Related]
39. Opposing effects of phorbol-12-myristate-13-acetate, an activator of protein kinase C, on the signaling of structurally related human dopamine D1 and D5 receptors.
Jackson A; Sedaghat K; Minerds K; James C; Tiberi M
J Neurochem; 2005 Dec; 95(5):1387-400. PubMed ID: 16313517
[TBL] [Abstract][Full Text] [Related]
40. Dopamine D2 receptor-mediated G protein activation assessed by agonist-stimulated [35S]guanosine 5'-O-(gamma-thiotriphosphate) binding in rat striatal membranes.
Odagaki Y; Toyoshima R
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Sep; 30(7):1304-12. PubMed ID: 16824659
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
